Ann: Appendix 4C - quarterly-BIQ.AX, page-3

It's an unnoticed company. IMHO, I believe it has lots of potentials. One thing I don't like is they rely part of their revenue on R&D grant. From my conservation projection,Ｉam expecting expense for the year around 11.6 million, Revenue of close to 10 million. That gives -1.5 million NPAT. If everything goes well I am expecting in 2017 they will have positive NPAT. All these estimation are taken without the impact of R&D grant and currency impact.

Let's put it this way, if they don't achieve +ve NPAT during 2017, with their current cash burning rate of close to $6m per year, the chance of them doing a CR is highly possible.

What's your personal view on it?